Skip to content

RanBP2 promotes ferroptosis resistance and compromises therapeutic response by stabilizing SLC7A1 through LRSAM1 SUMOylation and ubiquitination in lung adenocarcinoma.

Aug 2026 · Cell Death and Differentiation · 0 citations · 61 references
Medicine

TL;DR

This study demonstrates that RanBP2 exhibits elevated expression in LUAD and correlates with poor prognosis, and identifies a novel RanBP2-LRSAM1-SLC7A11 axis that promotes ferroptosis resistance and LUAD progression.

View source

Similar papers

Open access Sep 2026

TRIM46 drives lung adenocarcinoma progression by stabilizing PRDX1 via SUMOylation

Lung adenocarcinoma (LUAD) is one of the major subtypes of non-small cell lung cancer (NSCLC), but the molecular mechanisms underlying LUAD initiation and progression remain incompletely understood. In the present study, we identified TRIM46 as a key driver of LUAD progression. TRIM46 is significantly overexpressed i...

Shao-Kun Yu, Xiao Ke, Zhi-Li Liu et al. · 0 citations
Open access Aug 2026

Levistilide A promotes ferroptosis through the RNF40-HSP90α axis and inhibit colorectal cancer lung metastasis

It is demonstrated that heat shock protein 90α (HSP90α) is markedly upregulated in CRC and promotes lung metastasis by suppressing ferroptosis and combined treatment with LeA and the ferroptosis inducer RSL3 further alleviates lung metastatic burden in vivo.

Jia-Ming He, Chang-Shuo Li, Yingqiang Liu et al. · 0 citations
Open access Sep 2026

Glycolytic Reprogramming Mediated by the OTUD4-FXR1-HIF1A Axis Drives Gastric Cancer Progression

Findings uncover an OTUD4-FXR1-HIF1A signaling axis that promotes glycolysis, which in turn functionally drives gastric cancer progression, and thereby provides a potential prognostic biomarker and therapeutic target.

Fu-Lin Wang, Yu Shao, Xiao-Mei Zhuang et al. · 0 citations
Open access Sep 2026

PDLIM2 suppresses the progression of hepatocellular carcinoma via enhancing lipid peroxidation through promoting the ubiquitin-mediated proteasomal degradation of ARL14EP

Our previous studies have established that PDZ and LIM domain 2 (PDLIM2) played an inhibitory role in the progression of hepatocellular carcinoma (HCC). However, the underlying regulatory mechanisms remain incompletely understood. In this study, we identified ADP-ribosylation factor-like 14 effector protein (ARL14EP)...

Zhi-Yi Liu, Xue Zhang, Meng-Xuan Ji et al. · 0 citations
Open access Aug 2026

Fto-mediated m6A demsupplementethylation of SNHG9 Enhances PINK1-Dependent mitophagy and reverses cisplatin resistance via nuclear EZH2 ubiquitination.

Findings reveal a previously underappreciated mechanism of CDDP resistance driven by the FTO/SNHG9/VHL/EZH2/PINK1/Parkin axis and support the therapeutic potential of targeting this pathway in LUAD.

Zihan Jing, Xingmei Ren, Ruqiong Wang et al. · 0 citations
Oct 2026

CNOT4 Suppresses Bladder Cancer Progression by Promoting Ubiquitination-Mediated Degradation of EIF2AK2 and Inhibiting Autophagy.

EIF2AK2, also known as PKR, is a stress-responsive kinase that regulates multiple cellular processes, including autophagy, apoptosis, and tumor progression. However, the mechanisms underlying EIF2AK2 stability and function in bladder cancer (BLCA) remain underexplored. In this study, we investigated the mechanisms gove...

Ze-Chun Peng, Rui-Peng Jia, Tie-Min Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.